\documentclass[10pt,a4paper]{article} % Packages \usepackage{fancyhdr} % For header and footer \usepackage{multicol} % Allows multicols in tables \usepackage{tabularx} % Intelligent column widths \usepackage{tabulary} % Used in header and footer \usepackage{hhline} % Border under tables \usepackage{graphicx} % For images \usepackage{xcolor} % For hex colours %\usepackage[utf8x]{inputenc} % For unicode character support \usepackage[T1]{fontenc} % Without this we get weird character replacements \usepackage{colortbl} % For coloured tables \usepackage{setspace} % For line height \usepackage{lastpage} % Needed for total page number \usepackage{seqsplit} % Splits long words. %\usepackage{opensans} % Can't make this work so far. Shame. Would be lovely. \usepackage[normalem]{ulem} % For underlining links % Most of the following are not required for the majority % of cheat sheets but are needed for some symbol support. \usepackage{amsmath} % Symbols \usepackage{MnSymbol} % Symbols \usepackage{wasysym} % Symbols %\usepackage[english,german,french,spanish,italian]{babel} % Languages % Document Info \author{Carm (Carmilaa)} \pdfinfo{ /Title (hypertension-drugs.pdf) /Creator (Cheatography) /Author (Carm (Carmilaa)) /Subject (Hypertension Drugs Cheat Sheet) } % Lengths and widths \addtolength{\textwidth}{6cm} \addtolength{\textheight}{-1cm} \addtolength{\hoffset}{-3cm} \addtolength{\voffset}{-2cm} \setlength{\tabcolsep}{0.2cm} % Space between columns \setlength{\headsep}{-12pt} % Reduce space between header and content \setlength{\headheight}{85pt} % If less, LaTeX automatically increases it \renewcommand{\footrulewidth}{0pt} % Remove footer line \renewcommand{\headrulewidth}{0pt} % Remove header line \renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit % This two commands together give roughly % the right line height in the tables \renewcommand{\arraystretch}{1.3} \onehalfspacing % Commands \newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour \newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols \newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns \newcommand{\tn}{\tabularnewline} % Required as custom column type in use % Font and Colours \definecolor{HeadBackground}{HTML}{333333} \definecolor{FootBackground}{HTML}{666666} \definecolor{TextColor}{HTML}{333333} \definecolor{DarkBackground}{HTML}{F50C23} \definecolor{LightBackground}{HTML}{FEEFF1} \renewcommand{\familydefault}{\sfdefault} \color{TextColor} % Header and Footer \pagestyle{fancy} \fancyhead{} % Set header to blank \fancyfoot{} % Set footer to blank \fancyhead[L]{ \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{C} \SetRowColor{DarkBackground} \vspace{-7pt} {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}} } \end{tabulary} \columnbreak \begin{tabulary}{11cm}{L} \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Hypertension Drugs Cheat Sheet}}}} \\ \normalsize{by \textcolor{DarkBackground}{Carm (Carmilaa)} via \textcolor{DarkBackground}{\uline{cheatography.com/49544/cs/16839/}}} \end{tabulary} \end{multicols}} \fancyfoot[L]{ \footnotesize \noindent \begin{multicols}{3} \begin{tabulary}{5.8cm}{LL} \SetRowColor{FootBackground} \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}} \\ \vspace{-2pt}Carm (Carmilaa) \\ \uline{cheatography.com/carmilaa} \\ \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}} \\ \vspace{-2pt}Published 28th August, 2018.\\ Updated 28th August, 2018.\\ Page {\thepage} of \pageref{LastPage}. \end{tabulary} \vfill \columnbreak \begin{tabulary}{5.8cm}{L} \SetRowColor{FootBackground} \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}} \\ \SetRowColor{white} \vspace{-5pt} %\includegraphics[width=48px,height=48px]{dave.jpeg} Measure your website readability!\\ www.readability-score.com \end{tabulary} \end{multicols}} \begin{document} \raggedright \raggedcolumns % Set font size to small. Switch to any value % from this page to resize cheat sheet text: % www.emerson.emory.edu/services/latex/latex_169.html \footnotesize % Small font. \begin{multicols*}{4} \begin{tabularx}{3.833cm}{x{1.06423 cm} x{2.36877 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Introduction:}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{\textgreater{} most common CVS disease} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} \mymulticolumn{2}{x{3.833cm}}{\textgreater{} elevated arterial BP damages vessels in renal, heart and brain} \tn % Row Count 3 (+ 2) % Row 2 \SetRowColor{LightBackground} {\bf{Complications:}} & Renal failure, Coronary disease, Heart failure, Stroke, Diamentia \tn % Row Count 6 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.2132 cm} x{0.84924 cm} x{0.97056 cm} } \SetRowColor{DarkBackground} \mymulticolumn{3}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Classification:}}}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{Classification:}} & {\bf{Systolic BP}} & {\bf{Diastolic BP:}} \tn % Row Count 2 (+ 2) % Row 1 \SetRowColor{white} {\bf{Normal:}} & \textless{}120 & \textless{}80 \tn % Row Count 3 (+ 1) % Row 2 \SetRowColor{LightBackground} {\bf{Pre-hypertension:}} & 120-139 & 80-89 \tn % Row Count 5 (+ 2) % Row 3 \SetRowColor{white} {\bf{Stage 1 HTN:}} & 140-159 & 90-99 \tn % Row Count 6 (+ 1) % Row 4 \SetRowColor{LightBackground} {\bf{Stage 2 HTN:}} & \textgreater{}= 160 & \textgreater{}=100 \tn % Row Count 7 (+ 1) \hhline{>{\arrayrulecolor{DarkBackground}}---} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.64784 cm} x{1.78516 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Types of Hypertension:}}}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{Essential Hypertension (85-90\%):}} & Primary hypertension, no identifiable cause (genetic), can't be cured, can be controlled \tn % Row Count 5 (+ 5) % Row 1 \SetRowColor{white} {\bf{ Secondary Hypertension (10-15\%):}} & Specific identified cause (comorbid disease or drug), can be cured when cause is eliminated \tn % Row Count 10 (+ 5) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.61351 cm} x{1.81949 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Secondary Causes of HTN:}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{\textgreater{} Genetic factors} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} \mymulticolumn{2}{x{3.833cm}}{\textgreater{} Psychological stress} \tn % Row Count 2 (+ 1) % Row 2 \SetRowColor{LightBackground} \textgreater{} Environmental and Dietary Factors: & high salt diet, decreased calcium and phosphate intake, sedentary lifestyle \tn % Row Count 6 (+ 4) % Row 3 \SetRowColor{white} \textgreater{} Diseases: & renal, endocrine, vascular, renal diseases \tn % Row Count 8 (+ 2) % Row 4 \SetRowColor{LightBackground} \textgreater{} Drugs: & sympathomimetic amines, amphetamines, oral decongestants (eg. pseudoehedrine), corticosteroids, osteogens (C0Cs), NSAIDs, COX-2 inhibitors \tn % Row Count 15 (+ 7) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{0.92691 cm} x{2.50609 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Clinical presentation:}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{- Often incidental finding} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} \mymulticolumn{2}{x{3.833cm}}{- Adults should get BP checks once a year} \tn % Row Count 2 (+ 1) % Row 2 \SetRowColor{LightBackground} - Severe cases: & {\bf{Headaches}}, visual disturbances, target organ damage (stroke, ischemic heart disease, renal failure) \tn % Row Count 6 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Normal regulation of BP:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535481138_BP1.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Factors Influencing BP:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535481187_BP2.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.61351 cm} x{1.81949 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Potential Mechanisms of Parthogenesis:}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{{\bf{BP= CO x PVR}}} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} {\bf{Increased Cardiac output:}} & Increased fluid volume from excessive sodium intake or renal sodium retention Venous constriction: due to excess stimulation of RAAS \tn % Row Count 8 (+ 7) % Row 2 \SetRowColor{LightBackground} {\bf{Increased Peripheral resistance:}} & Excess stimulation of RAAS Sympathetic nervous system over-activity \tn % Row Count 12 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Antihypertensive Drugs:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535481396_BP3.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.33887 cm} x{2.09413 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Classes of Antihypertensive Agents:}}}} \tn % Row 0 \SetRowColor{LightBackground} \textgreater{} Diuretics: & Reduce blood volume=Depletes the body of sodium, Venodilation \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} \textgreater{} Sympathoplegic agents: & Reduce peripheral vascular resistance, Inhibit cardiac function, Increase venous pooling capacitance vessels \tn % Row Count 8 (+ 5) % Row 2 \SetRowColor{LightBackground} \textgreater{} Direct vasodilators: & Reduce peripheral vascular resistance, Increase venous pooling capacitance vessels \tn % Row Count 12 (+ 4) % Row 3 \SetRowColor{white} \textgreater{} Angiotensin antagonists: & Reduce peripheral vascular resistance, Reduce blood volume \tn % Row Count 15 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.57918 cm} x{1.85382 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Diuretics:}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{- Reduce blood volume and cardiac output} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} - Cardiac output returns to normal & But peripheral vascular resistance declines \tn % Row Count 4 (+ 3) % Row 2 \SetRowColor{LightBackground} - Sodium & Contributes to vascular resistance = Increase vessel stiffness \tn % Row Count 7 (+ 3) % Row 3 \SetRowColor{white} - Venodilation & Altered sodium-sodium calcium exchange \tn % Row Count 9 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Vasodilation mechanism by Diuretics:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535481896_BP4.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Thiazide Diuretics:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535481943_BP5.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Use of Diuretics:}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{1}{x{3.833cm}}{\textgreater{} Lower BP by 10-15 mmHg in most patients} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} \mymulticolumn{1}{x{3.833cm}}{\textgreater{} Thiazide diuretics –mild to moderate HTN} \tn % Row Count 2 (+ 1) % Row 2 \SetRowColor{LightBackground} \mymulticolumn{1}{x{3.833cm}}{\textgreater{} Loop diuretics – severe HTN and hypertensive emergencies} \tn % Row Count 4 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}-} \SetRowColor{LightBackground} \mymulticolumn{1}{x{3.833cm}}{{\bf{ Adverse Effects (Thiazide Diuretics):}} \newline Potassium depletion – hypokalemia \newline \newline Magnesium depletion \newline \newline Hyperuricemia- gouty attacks \newline \newline Glucose intolerance \newline \newline Increase serum lipid concentrations} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.68217 cm} x{1.75083 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{ Sympathoplegic Drugs:}}}} \tn % Row 0 \SetRowColor{LightBackground} {\bf{ Centrally-acting Drugs:}} & Methyldopa, clonidine \tn % Row Count 2 (+ 2) % Row 1 \SetRowColor{white} {\bf{Adrenoceptor antagonists}} & Beta-blockers, alpha-1 blockers \tn % Row Count 4 (+ 2) % Row 2 \SetRowColor{LightBackground} {\bf{ \seqsplit{Ganglionic-blocking} Agents:}} & No longer used clinically ; hexamethonium \tn % Row Count 7 (+ 3) % Row 3 \SetRowColor{white} {\bf{Adrenergic neuron blocking agents:}} & Block the release of noradrenaline, Reserpine, guanethidine, debrisoquin, Not/rarely used clinically \tn % Row Count 12 (+ 5) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.68217 cm} x{1.75083 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Centrally-Acting Drugs:}}}} \tn % Row 0 \SetRowColor{LightBackground} - Methyldopa, clonidine & rarely used except clondine \tn % Row Count 2 (+ 2) % Row 1 \SetRowColor{white} \mymulticolumn{2}{x{3.833cm}}{- Reduces sympathetic outflow} \tn % Row Count 3 (+ 1) % Row 2 \SetRowColor{LightBackground} - Compensatory response mechanism: & salt retention \tn % Row Count 5 (+ 2) % Row 3 \SetRowColor{white} - {\bf{Clonidine}}, guanabenz, guanfacine & Stimulate central alpha-2 adrenoceptors \tn % Row Count 7 (+ 2) % Row 4 \SetRowColor{LightBackground} - Methyldopa – anologue of L-dopa & Results in the synthesis of a false neurotransmitter \tn % Row Count 10 (+ 3) % Row 5 \SetRowColor{white} & \seqsplit{Alpha-methylnoradrenaline} = Stimulates central alpha-2 adrenoceptors \tn % Row Count 14 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{{\bf{Clonidine:}} \newline Reduces cardiac output, PVR, relaxation of capacitance vessels \newline Rarely causes postural hypotension \newline Adverse effects: \newline - Dry mouth \newline - Sedation \newline Contraindication: Patients with depression \newline {\bf{Caution: Abrupt discontinuation can lead to hypertensive crisis}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.44186 cm} x{1.99114 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Adrenoceptor antagonists: Beta-blockers}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{Non-selective: Propranolol} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} Beta-1 selective: "BBEAM" & Betaxolol, bisoprolol, esoprolol, {\bf{atenolol, metoprolol}}, Cardioselective \tn % Row Count 5 (+ 4) % Row 2 \SetRowColor{LightBackground} Vasodilator beta-blockers & Also block alpha-1 receptors,Labetolol, carvidelol, nebivolol \tn % Row Count 8 (+ 3) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{{\bf{Decrease cardiac output}} \newline \newline Decrease peripheral vascular resistance \newline \newline Inhibit stimulation of renin production by catecholamines \newline \newline Adverse effects= Heart block, bronchoconstriction, diabetes, vivid dreams} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.54485 cm} x{1.88815 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Alpha-1 blockers:}}}} \tn % Row 0 \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{{\bf{Prazosin}}, terazosin, doxazosin} \tn % Row Count 1 (+ 1) % Row 1 \SetRowColor{white} \mymulticolumn{2}{x{3.833cm}}{Block alpha-1 receptors in arterioles and veins} \tn % Row Count 2 (+ 1) % Row 2 \SetRowColor{LightBackground} Vasodilation & Reduce peripheral resistance \tn % Row Count 4 (+ 2) % Row 3 \SetRowColor{white} Compensatory mechanism: & salt and water retention \tn % Row Count 6 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{More effective when used with other drugs} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.20155 cm} x{2.23145 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Calcium Channel Blockers:}}}} \tn % Row 0 \SetRowColor{LightBackground} \textgreater{} \seqsplit{Dihydropyridines} & amlodipine, isradipine, nicardipine, nimodipine, felodipine, nisoldipine, lacidipine \tn % Row Count 4 (+ 4) % Row 1 \SetRowColor{white} \textgreater{} \seqsplit{Non-dihydropyridines} & Verapamil, diltiazem, hydralazine \tn % Row Count 6 (+ 2) % Row 2 \SetRowColor{LightBackground} & Benzothiazepine (diltiazem) \tn % Row Count 8 (+ 2) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{{\bf{Mechanism of action:}} \newline - Inhibit calcium influx through voltage-dependent L-type calcium channels \newline - Relax arteriolar smooth muscle, reduce peripheral vascular resistance \newline - Cause coronary and peripheral vasodilation} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.7165 cm} x{1.7165 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{CCB: Mechanisms of Action:}}}} \tn % Row 0 \SetRowColor{LightBackground} Dihydropyridine CCBs & Primary vasodilators (reduce PVR), All decrease cardiac contractility except amlodipine and felodipine \tn % Row Count 6 (+ 6) % Row 1 \SetRowColor{white} \seqsplit{Non-dihydropyridines} (diltiazem, verapamil) & directly block the AV node, decrease heart rate,decrease cardiac contraction \tn % Row Count 10 (+ 4) % Row 2 \SetRowColor{LightBackground} {\bf{Adverse effects:}} & 1. {\bf{Flushing, peripheral oedema, tachycardia, bradycardia, heartblock}} \tn % Row Count 14 (+ 4) \hhline{>{\arrayrulecolor{DarkBackground}}--} \SetRowColor{LightBackground} \mymulticolumn{2}{x{3.833cm}}{2. {\bf{Headache}}, flushing, dizziness, palpitations, hypotension \newline occur within a few hours of dosing, Associated w high initial doses or rapid increase in dose, Common with short-acting preparations \newline 3. Ankle oedema: Due to a rise in intracapillary pressure as a result of selective dilatation of precapillary arterioles, NOT due to sodium retention, Relieved by bed rest \newline 4. {\bf{Gum Hypertrophy:}} dihydropyridines \newline 5. GIT: constipation (verapamil), nausea, and vomiting} \tn \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{x{1.7165 cm} x{1.7165 cm} } \SetRowColor{DarkBackground} \mymulticolumn{2}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Inhibitors of Angiotensin:}}}} \tn % Row 0 \SetRowColor{LightBackground} Angiotensin converting enzyme inhibitors (ACEIs) & Captopril, enalapril, Ramipril, fosinopril, trandopril \tn % Row Count 3 (+ 3) % Row 1 \SetRowColor{white} Angiotensin receptor blockers (ARBs) & Losartan, valsartan, telmisartan, irbesartan, candesartan \tn % Row Count 6 (+ 3) % Row 2 \SetRowColor{LightBackground} Renin-inhibitors & Aliskiren \tn % Row Count 7 (+ 1) \hhline{>{\arrayrulecolor{DarkBackground}}--} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Inhibitors of Angiotensin:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535484450_BP6.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \SetRowColor{LightBackground} \mymulticolumn{1}{x{3.833cm}}{{\bf{Adverse Effects}} \newline ACEIs = \newline Dry cough \newline Can cause hyperkalemia – potassium monitoring essential \newline Angioedema (substance P?) \newline \newline ARBs = \newline No dry cough \newline {\bf{Hyperkalemia}} \newline Angiodema is less common than ACEIs \newline \newline Contraindicated in pregnancy} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Combination Treatment: Vasodilators:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535484504_BP7.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} \begin{tabularx}{3.833cm}{X} \SetRowColor{DarkBackground} \mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{{\bf{Management Approach:}}}} \tn \SetRowColor{LightBackground} \mymulticolumn{1}{p{3.833cm}}{\vspace{1px}\centerline{\includegraphics[width=5.1cm]{/web/www.cheatography.com/public/uploads/carmilaa_1535484825_BP8.PNG}}} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \SetRowColor{LightBackground} \mymulticolumn{1}{x{3.833cm}}{{\bf{First-line agents: "ACD" drugs:}} \newline - A: ACEIs and ARBs \newline - C: Calcium channel antagonists \newline - D: Diuretics (Thiazides) \newline \newline {\bf{Second-line agents:}} \newline - {\bf{Beta-adrenoceptor blockers}} \newline - Aldosterone antagonists (spironolactone, eplerenone) \newline - Alpha-blockers (doxazosin, prazosin, terazosin) \newline - Loop diuretics (frusemide, torsemide) \newline - Direct vasodilators (hydralazine, minoxidil) {[}last-line of therapy{]} \newline - Central α-2 agonists (clonidine) \newline - Adrenergic antagonists (reserpine)} \tn \hhline{>{\arrayrulecolor{DarkBackground}}-} \end{tabularx} \par\addvspace{1.3em} % That's all folks \end{multicols*} \end{document}